BriaCell TherapeuticsBCTX 
$0.5210.27%24h
10.27%24h
Global rank33248
Market cap$8.17M
Change 7d-20.79%
YTD Performance-91.14%
SP500 benchmarkUnderperform
P/E-0.40
P/S0
Revenue$0
Earnings-$20.30M
Dividend yield-
EPS for BriaCell Therapeutics (BCTX)
BriaCell Therapeutics has an EPS of $-1.3. In 2022, the company made an earnings per share (EPS) of $-1.73. Earnings Per Share (EPS) is a financial metric that measures a company's profit allocated to each outstanding share of its common stock. It is calculated by dividing the company's net earnings by the number of outstanding shares.
EPS for BCTX
-
Value:-
EPS history for BriaCell Therapeutics from 2001 to 2023
| Year | EPS | Change |
|---|---|---|
| 2023 | -$1.30 | -24.86% |
| 2022 | -$1.73 | 1822.22% |
| 2021 | -$0.09 | -98.40% |
| 2020 | -$5.64 | - |
View the highest EPS stocks
